GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval, said the drugmaker this morning. The fast-track ...
Once calling it his dream boat, Greg Biffle listed the yacht Checkered Past a year or so before the fatal jet crash. Asking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback